Novanta Inc Total Liabilities
Novanta Inc total liabilities. Based on the latest financial reports, Novanta Inc (NOVT) has total liabilities worth $523.11 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Novanta Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Novanta Inc (1998–2025)
Total liabilities of Novanta Inc from 1998 to 2025. This chart illustrates how Novanta Inc's total liabilities have evolved over time, based on quarterly financial data. Explore NOVT strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Novanta Inc Competitors by Total Liabilities
The table below lists competitors of Novanta Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Intercorp Financial Services Inc
NYSE:IFS
|
USA | $89.88 Billion |
|
Almonty Industries Inc
AU:AII
|
Australia | AU$231.92 Million |
|
LB Group Co Ltd
SHE:002601
|
China | CN¥36.55 Billion |
|
TEMENOS AG UNSP.ADR/1
F:TE8A
|
Germany | €1.83 Billion |
|
Sprouts Farmers Market LLC
NASDAQ:SFM
|
USA | $2.83 Billion |
|
Bank of Ayudhya Public Company Limited
F:NVAU
|
Germany | €2.21 Trillion |
|
Zalando SE
XETRA:ZAL
|
Germany | €6.01 Billion |
Liability Composition Analysis (1998–2025)
This chart breaks down Novanta Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Novanta Inc balance sheet assets.
Liquidity & Leverage Metrics
Novanta Inc Total Liabilities Ratios Explained
Novanta Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.57 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Novanta Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Novanta Inc (1998–2025)
The table below shows the annual total liabilities of Novanta Inc from 1998 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $492.82 Million | -23.33% |
| 2024-12-31 | $642.81 Million | +16.33% |
| 2023-12-31 | $552.60 Million | -16.73% |
| 2022-12-31 | $663.63 Million | -6.08% |
| 2021-12-31 | $706.59 Million | +81.94% |
| 2020-12-31 | $388.37 Million | -14.18% |
| 2019-12-31 | $452.56 Million | +28.82% |
| 2018-12-31 | $351.32 Million | -4.59% |
| 2017-12-31 | $368.24 Million | +120.81% |
| 2016-12-31 | $166.77 Million | -2.67% |
| 2015-12-31 | $171.34 Million | -8.06% |
| 2014-12-31 | $186.37 Million | +36.63% |
| 2013-12-31 | $136.40 Million | +24.85% |
| 2012-12-31 | $109.25 Million | -21.48% |
| 2011-12-31 | $139.14 Million | -54.46% |
| 2010-12-31 | $305.55 Million | -16.84% |
| 2009-12-31 | $367.42 Million | 0.00% |
| 2008-12-31 | $367.42 Million | +126.85% |
| 2007-12-31 | $161.97 Million | +137.03% |
| 2006-12-31 | $68.33 Million | +2.16% |
| 2005-12-31 | $66.89 Million | -17.01% |
| 2004-12-31 | $80.60 Million | +68.59% |
| 2003-12-31 | $47.81 Million | +12.21% |
| 2002-12-31 | $42.61 Million | -21.62% |
| 2001-12-31 | $54.36 Million | -61.70% |
| 2000-12-31 | $141.92 Million | +20.27% |
| 1999-12-31 | $118.00 Million | +273.42% |
| 1998-12-31 | $31.60 Million | -- |
About Novanta Inc
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets la… Read more